Markus F. Templin
0000-0002-6569-6489
Publication & Citation Trends
Publications
179 total
Personalized signaling pathway analysis of gastrointestinal tumors for patient stratification and drug target evaluation using clinically derived core biopsies
Cited by 0
Semantic Scholar
Genome-wide CRISPR-Cas9 screens identify BCL family members as modulators of response to regorafenib in experimental glioma
Cited by 3
Semantic Scholar
Discovery of PXR Antagonist MI891 and PXR Degrader MI1013 and Their Roles in Hepatic Gene Regulation
Cited by 5
Semantic Scholar
Regulation of neutrophil migration in acute pulmonary inflammation by extraneuronal α1 gamma-aminobutyric acidA receptors OA
Cited by 2
Semantic Scholar
Abstract A018: Functional, transcriptomic and genomic characterisation of CD19-directed CAR T-cells incorporating a TLR2 co-stimulatory domain
Cited by 0
Semantic Scholar
Clinical development of gene edited tacrolimus-resistant Treg (FKBP12KO-Treg) to enable simultaneous immunosuppression and support of immune regulation
Cited by 0
Semantic Scholar
JS04.7.A IDENTIFICATION OF BCL FAMILY MEMBERS AS MODULATORS OF REGORAFENIB EFFICACY IN EXPERIMENTAL GLIOMA
Cited by 0
Semantic Scholar
Functionally-instructed modifiers of response to ATR inhibition in experimental glioma OA
Cited by 3
Semantic Scholar
Research Topics
Monoclonal and Polyclonal Antibodies Research
(44)
Advanced Biosensing Techniques and Applications
(36)
Advanced Proteomics Techniques and Applications
(19)
Gene expression and cancer classification
(17)
Epigenetics and DNA Methylation
(10)
Affiliations
TH Bingen University of Applied Sciences
Max Planck Society
Inserm
University of Eastern Finland
Université de Montpellier